(Q50926038)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9359974%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9359974%20AND%20SRC:MED&resulttype=core&format=json

obsessive-compulsive disorder

7 November 2019

main subject

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9359974%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Brambilla F

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9359974%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Bellodi L

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9359974%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Arancio C

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9359974%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Bertani A

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9359974%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9359974%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9359974%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9359974%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9359974%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

889-897

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9359974%20AND%20SRC:MED&resulttype=core&format=json

Frontal lobe dysfunction in schizophrenia and obsessive-compulsive disorder: a neuropsychological study

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

CSF somatostatin in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Changes in Cerebrospinal Fluid Neurochemistry During Treatment of Obsessive-compulsive Disorder With Clomipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Plasma catecholamines and their metabolites in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Biogenic amine metabolism in tourette syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Hereditary agoraphobia and obsessive-compulsive behaviour in relatives of patients with Gilles de la Tourette's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Neuroanatomy of Gilles de la Tourette's Syndrome Possible Midbrain Involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

D2-agonist quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Neuroendocrine responses to intravenous L-tryptophan in obsessive compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Obsessions and compulsions in Gilles de la Tourette's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Influence of the menstrual cycle phase on the therapeutic response in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Obsessive-compulsive symptomatology in children with Tourette's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Dietary protein restriction impairs both spontaneous and growth hormone-releasing factor-stimulated growth hormone release in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Effects of fenfluramine on plasma HVA in OCD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Gilles de la Tourette syndrome after long-term chlorpromazine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Obsessive-compulsive symptoms following stimulants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

D-amphetamine in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Encephalitis lethargica, a contemporary cause of catatonic stupor. A report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Apomorphine in the evaluation of dopaminergic function in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Stimulant medications precipitate Tourette's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

The effect of glucose on growth hormone (GH)-releasing hormone-mediated GH secretion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Neural control of somatotropic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Further evidence for a specific role of estradiol in schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Successful treatment of obsessive-compulsive disorder with loxapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Serum antibody for somatostatin-14 and prodynorphin 209-240 in patients with obsessive-compulsive disorder, schizophrenia, Alzheimer's disease, multiple sclerosis, and advanced HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Dopamine D2 receptors are restricted to the prolactin cells in the rabbit pituitary gland: a combined autoradiographic and immunocytochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Evaluation of the reported association of obsessive-compulsive symptoms or disorder with Tourette's disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Molecular biology of dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Dopaminergic dysfunction in tourette syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

A review of GHRH stimulation test in psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Disappearance of hoarding behavior after 6-hydroxydopamine lesions of the mesolimbic dopamine neurons and its reinstatement with L-dopa

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900549-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(96)00549-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9359974%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference